香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其準確性或完整性亦不 發表任何聲明，並明確表示，概不就因本公佈全部或任何部份內容而產生或因倚賴該等內容而引致之任何損 失承擔任何責任。 （於開曼群島註冊成立之有限公司） （股份代號：419） 中期業績公佈 – 3 – 弘毅文化集團（「本公司」）董事會（「董事會」）欣然提呈本公司及其附屬公司（「本集團」）截至二零二五年六月三 十日止六個月之簡明綜合中期業績，連同二零二四年同期之比較數字。簡明綜合中期業績已經由本公司審核 委員會審閱。 簡明綜合中期收益表 截至二零二五年六月三十日止六個月 | | | 截至六月三十日止六個月 | | | --- | --- | --- | --- | | | | 二零二五年 | 二零二四年 | | | | （未經審核） | （未經審核） | | | 附註 | 千港元 | 千港元 | | 收入 | 4 | 302,381 | 489,398 | | 銷售成本 | | (222,235) | (356,200) | | 毛利 | | 80,146 | 133,198 | | 其他收入及其他收益淨額 | 4 | 1 ...

Core Viewpoint - ST Haofeng (300419.SZ) reported a significant decline in revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved an operating revenue of 101 million yuan, representing a year-on-year decrease of 41.74% [1] - The net profit attributable to shareholders was -7.0598 million yuan, indicating a loss [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -7.2548 million yuan [1] - The basic earnings per share were -0.0192 yuan [1]

格隆汇8月13日丨弘毅文化集团(00419.HK)宣布，公司将于2025年8月28日(星期四)举行董事会会议，藉 以批准刊发公司及其附属公司截至2025年6月30日止六个月的中期业绩公布，以及考虑派发中期股息(如 有)。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內 容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示 ， 概不就因本公佈全部或任何部分內容而產生或因倚賴該等內容而引致 的任何損失承擔任何責任。 1 執行董事 2 非執行董事 3 獨立非執行董事 弘毅文化集團（「本公司」）之董事會（「董事會」）宣佈，本公司 將於二零二 五 年八月二十 八 日（星期 四 ）舉行董事會會議，藉以批准 刊發本公司及其附屬公司截至二零二 五 年六月三十日止六個月之中期 業績公佈，以及考慮派發中期股息（如有）。 承董事會命 弘毅文化集團 公司秘書 侯偉文 香 港 ， 二零二五年 八 月 十 三 日 於本公佈日期，董事會成員包括： 趙令歡先生 2 （主席）、程武先生 1 （首席執行官）、袁海波先生 1 （ 總 裁）、袁健先生 3 、初育国先生 3 、王宋宋女士 3 及潘敏女士 3 （於 開 曼 群 島 註 冊 成 立 之 有 限 公 司） （股 份 代 號：419） 董事會會議通告 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 弘毅文化集團(於開曼群島註冊成立之有限公司) 呈交日期: 2025年8月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00419 | 說明 | | | | | | | | | 法定/註冊股份數目 | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | 150,000,000,000 | HKD | | 0.02 HKD | | 3,000,000,000 | | 增加 / 減少 (-) | | 0 | | | HKD | | 0 | | 本月底結存 | | 150,000,000,000 | HKD | | 0.02 HKD | | 3,000,000,000 | | 2. 股份分類 | 優先股 | 股份 ...

Summary of Key Points Core Viewpoint - As of July 3, a total of 120 stocks reached their 52-week highs, indicating a strong market performance with notable leaders in the list [1]. Group 1: Top Performers - The top three stocks with the highest increase rates are: - 富誉控股 (Fuyou Holdings) at 90.76%, closing at 0.435 with a peak of 0.475 [1] - 信义能源 (Xinyi Energy) at 65.00%, closing at 1.200 with a peak of 1.980 [1] - 中国三三传媒 (China San San Media) at 42.86%, closing at 1.710 with a peak of 1.900 [1] Group 2: Additional Notable Stocks - Other notable stocks include: - ITE HOLDINGS at 34.21% increase, closing at 0.047 with a peak of 0.051 [1] - 星凯控股 (Xingkai Holdings) at 30.00%, closing at 0.480 with a peak of 0.650 [1] - 北京北辰实业股份 (Beijing Beichen Industrial) at 26.47%, closing at 0.940 with a peak of 1.290 [1] Group 3: Overall Market Trends - The overall trend shows a significant number of stocks achieving new highs, reflecting positive investor sentiment and market conditions [1].

金融界消息 截至2025年5月21日收盘，ST浩丰（300419）报收于5.39元，上涨3.26%，换手率3.74%，成 交量13.75万手，成交金额7397.04万元。 通过天眼查大数据分析，北京浩丰创源科技股份有限公司共对外投资了15家企业，参与招投标项目422 次，知识产权方面有商标信息15条，专利信息1条，此外企业还拥有行政许可5个。 来源：金融界 ST浩丰最新一期业绩显示，截至2025一季报，公司营业总收入4543.51万元、同比减少20.58%，归属净 利润503.24万元，同比减少40.85%，扣非净利润518.45万元，同比减少32.84%，流动比率1.719、速动比 率1.498、资产负债率36.64%。 天眼查商业履历信息显示，北京浩丰创源科技股份有限公司，成立于2005年，位于北京市，是一家以从 事科技推广和应用服务业为主的企业。企业注册资本36775.377万人民币，实缴资本36775.377万人民 币。公司法定代表人为王剑。 资金流向方面，今日主力资金净流入1730.53万元，占比成交额23.39%。其中，超大单净流入548.45万 元、占成交额7.41%，大单净流入1182.08万 ...

Financial Performance - The group's revenue from continuing operations for the year ended December 31, 2024, was HKD 1.018 billion, a decrease of 24% compared to the previous year[12]. - The main revenue source, the digital operation service "Yizhi Nuo," generated HKD 869 million, down 8% year-on-year, due to changes in business and client structures driven by medical reform policies[12]. - The "Mango Health" platform recorded revenue of HKD 146 million, a significant decline of 63%, primarily due to restructuring efforts that divested loss-making segments[12]. - The company reported a loss of approximately HKD 177.19 million for the year, an increase of 41% compared to HKD 125.35 million in the previous year[13]. - Financing costs rose to approximately HKD 17.61 million, up from HKD 3.61 million in the previous year, primarily due to interest expenses from convertible bonds issued in March 2024[13]. - The revenue for the year ended December 31, 2024, was HKD 869,555,000, a decrease of 8% compared to HKD 943,936,000 in 2023[28]. - The gross profit margin for 2024 was 38.7%, down from 40.7% in 2023, reflecting a slight decline of 2.0%[28]. - The loss from continuing operations for the year was HKD 177,190,000, an increase of 48% compared to HKD 119,567,000 in 2023[48]. - The adjusted loss from continuing operations was HKD 103,235,000, a slight improvement of 3% from HKD 106,466,000 in 2023[48]. Business Strategy and Development - The company is focusing on developing high-quality clients and enhancing the core competitiveness of its digital operation services[9]. - The board plans to implement specific development directions for international culture, media, and entertainment businesses to realize the group's vision[10]. - The company is exploring opportunities in the rapidly evolving global culture, entertainment, and media markets, driven by technological innovations and changing consumer habits[8]. - The company aims to build a global content creation platform, focusing on international culture, media, and entertainment business development[13]. - The company is committed to optimizing its digital operation services and smart health service platforms while integrating resources for global market expansion[7]. - The company has successfully entered the second phase of its business model with the launch of the "Ciyuan Platform," providing comprehensive digital transformation services for pharmaceutical companies[18]. - The company initiated an AI Smart Laboratory project in 2024, enhancing the efficiency and quality of medical services through interactive and personalized solutions[19]. - The company aims to enhance its supply chain sustainability by regularly evaluating supplier compliance and performance[45]. Corporate Governance - The board of directors consists of seven members, responsible for setting company policies, business goals, and monitoring financial performance[73]. - The board held a total of six meetings during the reporting period, with all members actively participating[75]. - The corporate governance committee held one meeting to review training and development for directors and senior management, as well as compliance with governance codes[80]. - The nomination committee conducted two meetings to assess board structure and diversity, reaffirming commitment to gender diversity[82]. - The remuneration committee is responsible for establishing a transparent remuneration policy for all directors and senior management[83]. - The company has complied with the corporate governance code, except for a temporary non-compliance regarding the separation of roles between the chairman and CEO[72]. - The company has established various committees, including the executive, governance, nomination, remuneration, and audit committees, to ensure effective governance[77]. - The board consists of seven directors as of December 31, 2024, including two women, representing 28.6% gender balance[88]. Environmental, Social, and Governance (ESG) Initiatives - The ESG report for the year 2024 aims to objectively disclose the group's compliance status and performance in environmental, social, and governance aspects[123]. - The report adheres to the principles of materiality, quantification, balance, and consistency to ensure accuracy and reliability[125]. - The group has established an ESG framework led by the board, focusing on sustainable development strategies and enhancing risk management capabilities[127]. - A dedicated ESG working group has been set up to oversee the implementation of sustainability strategies and ensure compliance with regulatory requirements[128]. - The group identified 19 significant ESG issues impacting operations, emphasizing the importance of stakeholder engagement in shaping its sustainability strategy[131]. - The group has implemented strict supplier evaluation standards to ensure the quality and safety of products, adhering to relevant laws and regulations[137]. - The group has established a quality management team to oversee product information and ensure compliance with quality standards, achieving ISO 9001:2015 certification[138]. - The group has developed a comprehensive response plan for handling customer complaints and emergencies, ensuring effective management of incidents[139]. Employee and Workplace Policies - The employee turnover rate is 27.54%, with a higher rate of 31.45% for male employees and 27.93% for those in mainland China[148]. - The group has implemented strict compliance measures, including signing compliance commitment letters for new employees[145]. - The group has conducted anti-corruption training for all board members and employees to enhance awareness[146]. - The group has a total of 221 full-time employees, with 109 males and 112 females[148]. - The average training hours for male employees is 3.79 hours, while for female employees it is 6.11 hours, with 100% participation in training across all categories[153]. - Senior management received an average of 11.43 training hours, while middle management received 4.76 hours, and regular employees received 4.44 hours, all with 100% participation[153]. Financial Position and Ratios - The current ratio improved from 0.72 on December 31, 2023, to 1.02 on December 31, 2024, indicating better liquidity[63]. - The debt-to-equity ratio as of December 31, 2024, was 4.9 times, a significant increase from 27.21% in 2023, primarily due to the issuance of convertible bonds amounting to HKD 120,000,000[64]. - The total bank and other borrowings amounted to approximately HKD 75,051,000 as of December 31, 2024, compared to HKD 72,231,000 in 2023[66]. - The group had a net foreign exchange loss of approximately HKD 1,879,000 during the year, compared to HKD 1,508,000 in the previous year, due to fluctuations in the Chinese Yuan and Korean Won against the Hong Kong Dollar[65]. Community Engagement and Social Responsibility - The company aims to increase community investment and promote industry collaboration and social responsibility practices to support the construction of a healthy China[175]. - The company plans to donate consultation cards to promote healthcare resources to grassroots levels, enhancing accessibility and fairness in medical services[175]. - The company is committed to corporate social responsibility, focusing on supporting local community development through job creation[46].

于股权转让协议完成后，獴哥集团成员公司将成为该公司的全资附属公司，且不再存有任何合约安排， 而獴哥集团的财务业绩将继续并入该集团财务报表。 根据股权转让协议，该集团能够按名义对价取得獴哥集团少数股东所持部分股权的所有权，令公司全资 拥有獴哥集团(连同其营运业务)。如此精简獴哥集团的企业架构将令集团自主且全面掌控獴哥集团及獴 哥健康业务的未来企业与业务发展，并悉数享有其所产生的经济效益。 智通财经APP讯，弘毅文化集团(00419)公布，就獴哥健康业务而言，獴哥集团已剥离其疫苗和体检业 务，终止其私域电商业务，并专注于运营健康消费业务， 而VIE 合约安排项下 的VIE 结构将不再属必 要。 公司已于2025年4月1日与ESOP及自然人SPV订立合资平台(即Meerkat Health Holdings Limited)股权转让 文件，旨在收购彼等合共持有合资平台的40%股权，令合资平台及其附属公司成为该集团的全资附属公 司。同日，WFOE与中国股权拥有人分别订立OPCO股权转让协议A及OPCO股权转让协议B，供彼等向 WFOE转让各自于OPCO持有的60%及40%股权;WFOE及OPCO亦就终止VIE合约安排 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其準 確性或完整性亦不發表任何聲明，並明確表示，概不就因本公佈全部或任何部份內容而產 生或因倚賴該等內容而引致之任何損失承擔任何責任。 Hony Media Group 弘 毅 文 化 集 團 （ 於開曼群島註冊成立之有限公司） （股份代號：419） 中期業績公佈 華誼騰訊娛樂有限公司（「本公司」）董事會（「董事會」）欣然提呈本公司及其附屬公司（「本集 團」）截至二零二四年六月三十日止六個月之簡明綜合中期業績，連同二零二三年同期之比 較數字。簡明綜合中期業績已經由本公司審核委員會審閱。 簡明綜合中期收益表 截至二零二四年六月三十日止六個月 截至六月三十日止六個月 | --- | --- | |--------------------------------------------|--------------------------------------------------| | | | | 二零二 四 年 | 二 零 二三 年 | | （ 未 經 審 核 ） （ | 未 經 審 核 ） （ 經 重 列 ） （ 附 註 26 ） ...